比速科技(01372.HK)擬發行4000萬股認購股份 淨籌1.92億港元用於開發碳中和業務
格隆匯 3 月 8日丨比速科技(01372.HK)發佈公吿,2021年3月7日,公司(作為發行人)與各認購人訂立認購協議,內容有關按認購價每股4.80港元認購合共4000萬股認購股份。認購股份合共相當於公司現有已發行股本20.00%及經股份擴大後已發行股本約16.67%。
根據披露,認購人包括Mao Yuan Capital Limited(懋源資本有限公司)及張亞循先生。Mao Yuan Capital Limited(懋源資本有限公司)為一家於英屬處女羣島註冊成立的有限責任公司,專注於香港資本市場的戰略性及財務性投資。張亞循先生為具有豐富經驗的專業投資人和實業家。其自2006年至今出任安圖生物(603658.SH)董事兼副董事長。安圖生物主要從事體外診斷試劑及儀器的研發、生產和銷售,其市值於本公吿日期已超過人民幣500億元。根據公開披露,張先生通過Z&F International Trading Limited間接持有安圖生物的約13%股權。其亦是河南爭鋒農牧科技發展有限公司董事長。
誠如過往公佈,公司將規劃開始投資全球碳中和業務。業務擴展需要公司擴充資金規模,以改善集團的盈利能力和發展能力。在研究了多種集資行動的可行性後,公司認為除少量的專業費用外,認購事項不會產生利息費用或其他支出;定向增發可確保公司在短期獲得一定數量的資金;及以現金為代價發行新股可大幅改善公司財務狀況,例如提高流動率、降低資產負債率及改善整體抗風險能力。
認購事項所得款項淨額將約為1.92億港元,其中60,00萬港元擬用作集團的一般營運資金及╱或償還集團債務,而餘下1.32億港元擬用於開發碳中和業務及╱或探索其他潛在新業務。除已披露的碳中和業務外,集團尚未決定踏足其他新業務。公司作於出現新業務進展時根據上市規則作出適當公吿。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.